Skip to content

EBIT at other companies

CONMED logo
CONMEDCNMD
$25.42M+59.3%
Enovis logo
EnovisENOV
$6.53M+114%
OrthoPediatrics logo
OrthoPediatricsKIDS
-$8.34M+24.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-22.3%
Enterprise value$320.25M-19.0%
P/S1.3×-0.3×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s EBIT?
Treace Medical Concepts, Inc. (TMCI) reported EBIT of -$17.17M in Q1 2026.
How has Treace Medical Concepts, Inc.'s EBIT changed year-over-year?
Treace Medical Concepts, Inc.'s EBIT decreased by 10.2% year-over-year, from -$15.58M to -$17.17M.
What is the long-term trend for Treace Medical Concepts, Inc.'s EBIT?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s EBIT has grown at a 34.6% compound annual growth rate (CAGR), from -$16.51M to -$54.15M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.